HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J A Stewart Selected Research

Brimonidine Tartrate (Alphagan)

1/2005Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
10/2004Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.
7/2004Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension.
5/2001The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension.
12/2000Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension.
6/2000Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J A Stewart Research Topics

Disease

12Open-Angle Glaucoma (Glaucoma, Open Angle)
07/2008 - 06/2000
8Ocular Hypertension (Glaucoma, Suspect)
01/2005 - 06/2000
4Glaucoma
01/2009 - 06/2001
3Hyperemia
03/2008 - 05/2001
2Hypothermia
12/2020 - 02/2000
2Breast Neoplasms (Breast Cancer)
06/2014 - 03/2013
1Type 2 Diabetes Mellitus (MODY)
07/2006
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
03/2006
1Multiple Sclerosis
03/2006
1Pain (Aches)
09/2004
1Infections
09/2000
1Exanthema (Rash)
09/2000
1Measles
09/2000
1Rubella (German Measles)
09/2000
1Pruritus (Itching)
06/2000
1Infarction (Infarctions)
02/2000
1Ischemic Stroke
02/2000
1Stroke (Strokes)
02/2000

Drug/Important Bio-Agent (IBA)

7Timolol (Blocadren)FDA LinkGeneric
01/2009 - 06/2001
7Latanoprost (Xalatan)FDA Link
01/2009 - 12/2000
6dorzolamide (Trusopt)FDA LinkGeneric
07/2008 - 06/2000
6Brimonidine Tartrate (Alphagan)FDA LinkGeneric
01/2005 - 06/2000
2Bimatoprost (Lumigan)FDA Link
03/2008 - 05/2005
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2014
1XELOXIBA
03/2013
1Capecitabine (Xeloda)FDA Link
03/2013
1taxaneIBA
03/2013
1Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2013
1AnthracyclinesIBA
03/2013
1ProstaglandinsIBA
03/2008
1Insulin (Novolin)FDA Link
07/2006
1Metformin (Glucophage)FDA LinkGeneric
07/2006
1Insulin Glargine (Lantus)FDA Link
07/2006
1Glucose (Dextrose)FDA LinkGeneric
07/2006
1Dihydroorotate DehydrogenaseIBA
03/2006
1teriflunomideIBA
03/2006
1brinzolamide (Azopt)FDA Link
09/2004
1SolutionsIBA
06/2001
1isopropyl unoprostone (Rescula)FDA Link
03/2001
1AntigensIBA
09/2000
1Immunoglobulin G (IgG)IBA
09/2000
1Immunoglobulin M (IgM)IBA
09/2000
1Proteins (Proteins, Gene)FDA Link
09/2000
1NeurotensinIBA
02/2000
1AnticoagulantsIBA
02/2000
1Antihypertensive Agents (Antihypertensives)IBA
02/2000

Therapy/Procedure

6Therapeutics
03/2013 - 02/2000
1Anesthesia
12/2020
1Drug Therapy (Chemotherapy)
03/2013
1Secondary Prevention
02/2000